Cargando…
Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review
OBJECTIVES: Low back pain (LBP) is the leading cause of disability and work absenteeism globally, and it poses significant clinical and economic burden to individuals, health systems and the society. This study aimed to synthesise the clinical and economic burden of LBP in low-income and middle-inco...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151982/ https://www.ncbi.nlm.nih.gov/pubmed/37185180 http://dx.doi.org/10.1136/bmjopen-2022-064119 |
_version_ | 1785035657296478208 |
---|---|
author | Fatoye, Francis Gebrye, Tadesse Mbada, Chidozie Emmanuel Useh, Ushotanefe |
author_facet | Fatoye, Francis Gebrye, Tadesse Mbada, Chidozie Emmanuel Useh, Ushotanefe |
author_sort | Fatoye, Francis |
collection | PubMed |
description | OBJECTIVES: Low back pain (LBP) is the leading cause of disability and work absenteeism globally, and it poses significant clinical and economic burden to individuals, health systems and the society. This study aimed to synthesise the clinical and economic burden of LBP in low-income and middle-income countries (LMICs). METHODS: A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was performed. PubMed, Medline, CINAHL, PsycINFO, AMED, Embase and Scopus databases were systematically searched for studies that examined the clinical and economic burden of LBP in LMICs, published from inception to 10 December 2021. Only studies with clearly stated methodologies and published in English were eligible for review. RESULTS: Nine studies met the inclusion criteria and were reviewed. Of these, three of them were clinical burden studies. The mean Newcastle–Ottawa Quality Assessment Scale (NOS) score of the included studies was 4, with an average from 3 to 6. The included studies were conducted in Argentina, Brazil, China, Ethiopia, Nigeria and Republic of Serbia. The rates of hospitalisation due to LBP ranged between 13.4% and 18.7%. Due to variation of methodological approaches, the reported cost estimates were inconsistent across the studies. A total cost of US$2.2 billion per population and US$1226.25 per patient were reported annually due to LBP. CONCLUSION: This systematic literature review suggests that LBP is associated with significantly high rates of hospitalisation and costs. As LBP is an important threat to the population, health professionals and policymakers are to put in place appropriate programmes to reduce the clinical and economic burden associated with LBP and improve the health outcomes of individuals with this condition in LMICs. PROSPERO REGISTRATION NUMBER: CRD42020196335. |
format | Online Article Text |
id | pubmed-10151982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-101519822023-05-03 Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review Fatoye, Francis Gebrye, Tadesse Mbada, Chidozie Emmanuel Useh, Ushotanefe BMJ Open Global Health OBJECTIVES: Low back pain (LBP) is the leading cause of disability and work absenteeism globally, and it poses significant clinical and economic burden to individuals, health systems and the society. This study aimed to synthesise the clinical and economic burden of LBP in low-income and middle-income countries (LMICs). METHODS: A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was performed. PubMed, Medline, CINAHL, PsycINFO, AMED, Embase and Scopus databases were systematically searched for studies that examined the clinical and economic burden of LBP in LMICs, published from inception to 10 December 2021. Only studies with clearly stated methodologies and published in English were eligible for review. RESULTS: Nine studies met the inclusion criteria and were reviewed. Of these, three of them were clinical burden studies. The mean Newcastle–Ottawa Quality Assessment Scale (NOS) score of the included studies was 4, with an average from 3 to 6. The included studies were conducted in Argentina, Brazil, China, Ethiopia, Nigeria and Republic of Serbia. The rates of hospitalisation due to LBP ranged between 13.4% and 18.7%. Due to variation of methodological approaches, the reported cost estimates were inconsistent across the studies. A total cost of US$2.2 billion per population and US$1226.25 per patient were reported annually due to LBP. CONCLUSION: This systematic literature review suggests that LBP is associated with significantly high rates of hospitalisation and costs. As LBP is an important threat to the population, health professionals and policymakers are to put in place appropriate programmes to reduce the clinical and economic burden associated with LBP and improve the health outcomes of individuals with this condition in LMICs. PROSPERO REGISTRATION NUMBER: CRD42020196335. BMJ Publishing Group 2023-04-25 /pmc/articles/PMC10151982/ /pubmed/37185180 http://dx.doi.org/10.1136/bmjopen-2022-064119 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Global Health Fatoye, Francis Gebrye, Tadesse Mbada, Chidozie Emmanuel Useh, Ushotanefe Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review |
title | Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review |
title_full | Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review |
title_fullStr | Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review |
title_full_unstemmed | Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review |
title_short | Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review |
title_sort | clinical and economic burden of low back pain in low- and middle-income countries: a systematic review |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151982/ https://www.ncbi.nlm.nih.gov/pubmed/37185180 http://dx.doi.org/10.1136/bmjopen-2022-064119 |
work_keys_str_mv | AT fatoyefrancis clinicalandeconomicburdenoflowbackpaininlowandmiddleincomecountriesasystematicreview AT gebryetadesse clinicalandeconomicburdenoflowbackpaininlowandmiddleincomecountriesasystematicreview AT mbadachidozieemmanuel clinicalandeconomicburdenoflowbackpaininlowandmiddleincomecountriesasystematicreview AT usehushotanefe clinicalandeconomicburdenoflowbackpaininlowandmiddleincomecountriesasystematicreview |